Essential Acute Stroke Care in Low Resource Settings: a Pilot studY
NCT ID: NCT04157231
Last Updated: 2025-03-06
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
NOT_YET_RECRUITING
NA
300 participants
INTERVENTIONAL
2025-12-30
2027-12-30
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Implementing International Standards of Practice in A Low Resource Country by Blended Training Modules to Improve Stroke Care
NCT04995146
Chinese Acute Ischemic Stroke Treatment Outcome Registry
NCT02470624
Quality Assessment in Acute Stroke Care
NCT00574262
Registry of Acute Ischemic Stroke With Large- or Medium-vessel Occlusion
NCT05779215
Telestroke 2: Prehospital Triage of Patients With Suspected Stroke Using Onsite Mobile Telemedicine
NCT04578002
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
NON_RANDOMIZED
SEQUENTIAL
SUPPORTIVE_CARE
SINGLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Usual Care
Usual care to be provided to patients as per hospital guidelines for 3 months
No interventions assigned to this group
Intervention arm
The intervention consists of training and education of the site staff about the treatment protocol for the different components of the management plan will be provided on two occasions. This intervention will run for 3 months.
Refresher training will be given monthly during the intervention.
Acute stroke care Intervention arm
Training and education of the site staff about the treatment protocol for the different components of the management plan will be provided on two occasions. The aim of these sessions will be to educate stroke champions and other site staff on the management protocols. Available training resources will be accessed (including online materials) and simulation training will be used. New skills such as dysphagia assessment will be emphasized based on existing knowledge and competencies. After training, staff will have another assessment (Post-test) in order to determine whether they have been adequately trained and are able to adhere to the essential acute stroke care management plan. A standardised Power Point presentation and accompanying handouts will be made available for further use in the ward.
Refresher training will be provided monthly during the intervention.
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Acute stroke care Intervention arm
Training and education of the site staff about the treatment protocol for the different components of the management plan will be provided on two occasions. The aim of these sessions will be to educate stroke champions and other site staff on the management protocols. Available training resources will be accessed (including online materials) and simulation training will be used. New skills such as dysphagia assessment will be emphasized based on existing knowledge and competencies. After training, staff will have another assessment (Post-test) in order to determine whether they have been adequately trained and are able to adhere to the essential acute stroke care management plan. A standardised Power Point presentation and accompanying handouts will be made available for further use in the ward.
Refresher training will be provided monthly during the intervention.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* A clinical or imaging-based diagnosis of acute stroke (ischemic or haemorrhagic) within 72 hours of stroke symptom onset
* Provision of written informed consent
* Subjects in observational, natural history and/or epidemiological studies not involving an intervention are eligible.
Exclusion Criteria
* Patients who are planned for transfer to the intensive care unit
* Subarachnoid haemorrhage
* Participation in an interventional medical investigation or clinical trial currently or within the past 3 months.
18 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
World Heart Federation
UNKNOWN
The George Institute
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Carlos Abanto, Dr
Role: PRINCIPAL_INVESTIGATOR
National Institute of Neurological Sciences, Lima, Peru
Kolawawole Wahab, Professor
Role: PRINCIPAL_INVESTIGATOR
University of Ilorin & University of Ilorin Teaching Hospital Ilorin, Nigeria
Hasan Farhan, Professor
Role: PRINCIPAL_INVESTIGATOR
President of Iraqi Scientific Council of Cardiology,Iraq
Yi Sui, Dr
Role: PRINCIPAL_INVESTIGATOR
Shenyang First People's Hospital Hospital Affiliated Brain Hospital
Saima Hilal, A/Professor
Role: PRINCIPAL_INVESTIGATOR
National University of Singapore
Lily Song, Dr
Role: PRINCIPAL_INVESTIGATOR
The George Institute of Global Health, China
Craig Anderson, Professor
Role: PRINCIPAL_INVESTIGATOR
Executive Director The George Institute for Global Health - China
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Murtala Muhammad Specialist Hospital
Kano, Kano State, Nigeria
Federal Medical Centre
Lokoja, Kogi State, Nigeria
Hospital de Apoyo II-2 Sullana
Piura, , Peru
Hospital de la Amistad Peru Corea Santa Rosa II-2
Piura, , Peru
Countries
Review the countries where the study has at least one active or historical site.
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Facility Contacts
Find local site contact details for specific facilities participating in the trial.
Dr Babatunde Ademiluyi, Dr
Role: primary
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
GI_NM-01-2019
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.